Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-02-24Clinical Trial Update: Robotic vs. Open NSM for Early Stage Breast Cancer [NA]
A clinical trial update indicates the study comparing robotic-assisted nipple-sparing mastectomy with open nipple-sparing mastectomy for ear…
-
EMA approval · 2026-02-23EMA Authorised: Inluriyo (imlunestrant tosilate) — Eli Lilly Nederland B.V.
EMA authorised Inluriyo (imlunestrant tosilate) for breast cancer, with Eli Lilly Nederland B.V. as the marketing authorisation holder.
-
EMA approval · 2026-02-23EMA Authorised: Ogivri (trastuzumab) — Biosimilar Collaborations Ireland Limited
The EMA authorised Ogivri, a trastuzumab biosimilar from Biosimilar Collaborations Ireland Limited, for gastric cancer and breast cancer.
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Using Machine Learning Models.
A completed clinical trial from Florence Nightingale Hospital Istanbul evaluated machine learning models to predict pathologic complete resp…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Tucatinib and Trastuzumab in HER3-mutant and HER2-not Amplified Metastatic Breast Cancer [Phase 2]
Phase 2 study evaluating tucatinib in combination with trastuzumab for patients with HER3-mutant and HER2-non-amplified metastatic or unrese…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer [NA]
A Johns Hopkins University clinical trial is examining whether treating insomnia influences behavioral weight loss outcomes in breast cancer…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer [Phase 3]
A Phase 3 trial is evaluating Trastuzumab deruxtecan (T-DXd) alone or in sequence with THP versus standard ddAC-THP in HER2-positive early b…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
This document summarizes an interview-based update from a completed trial of capivasertib plus fulvestrant in HR+/HER2- metastatic breast ca…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Olaparib + Sapacitabine in BRCA Mutant Breast Cancer [Phase 1]
Phase 1 trial updating the combination of olaparib with sapacitabine in BRCA-mutant breast cancer. The study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)
This completed qualitative study investigates how patients with metastatic breast cancer and their clinicians can improve shared decision-ma…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Weight Management After Cancer for Survivors in Rural Communities [NA]
A Duke University-sponsored clinical trial is evaluating weight management among breast cancer survivors in rural communities. The study is …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study [Phase 2]
A multi-centre Phase II feasibility trial evaluating tucatinib, trastuzumab, and capecitabine with brain/spinal radiotherapy in patients wit…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-world
A completed real-world study assessing the effectiveness and tolerability of alpelisib in patients with PIK3CA-mutant breast cancer.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer [Phase 2]
Phase 2 study to evaluate the safety and tolerability of Camizestrant in combination with Atirmociclib in women with advanced breast cancer.…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: An Investigational Scan (64Cu-DOTA-Trastuzumab PET/MRI) in Imaging Patients With HER2+ Breast Cancer With Brain Metastasis [Phase 4]
Phase 4 trial evaluating 64Cu-DOTA-Trastuzumab PET/MRI for imaging HER2-positive breast cancer with brain metastases; currently recruiting a…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Circulating Tumour Cells Characterization in Breast Cancer Patients
A clinical trial in breast cancer is currently recruiting to characterize circulating tumor cells in patients.
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Lymph Node Identification Using Magtrace and Magseed Before Chemotherapy
A breast cancer clinical trial is recruiting to test lymph node identification using magnetic tracers Magtrace and Magseed before chemothera…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring [NA]
Carevive Systems is conducting a real-world study evaluating remote symptom monitoring for patients with breast cancer, lung cancer, gastroi…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: ROLL Versus Magnetic Seed for Preoperative Localization of Non-palpable Breast Lesion: Comparison Between Techniques.
This clinical trial compares radioguided occult lesion localization (ROLL) with magnetic seed localization for preoperative marking of non-p…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: The Active After Cancer Trial (AACT) [NA]
Clinical trial update for the Active After Cancer Trial (AACT). The study is currently active but not recruiting, and it involves breast can…
-
CLINICAL_TRIALS trial_result · 2026-02-23Clinical Trial Update: Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab [NA]
A clinical trial update from Virginia Commonwealth University evaluating cardiovascular health education via virtual reality for breast canc…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: IRIS: Risk-Based Imaging After Breast-Conserving Surgery [NA]
This entry reports a clinical trial named IRIS evaluating risk-based imaging after breast-conserving surgery for breast cancer; the study is…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
A clinical trial update describing a real-world study on treatment experiences for breast, lung, ovarian cancer, multiple myeloma, and acute…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer [Phase 2]
Phase 2 trial investigating ctDNA-guided omission of chemotherapy in combination with ribociclib and endocrine therapy for HR-positive/HER2-…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: GammaPod Dose Escalation Radiation for Early Stage Breast Cancer [NA]
This clinical trial is evaluating dose escalation of GammaPod radiation for early-stage breast cancer and is currently recruiting. Sponsored…